Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Recent Advances in Contrast-Enhanced Ultrasound in Woman Pelvis Lesions

  • Chapter
Enhancing the Role of Ultrasound with Contrast Agents

  • 829 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Marret H, Tranquart F, Sauget S, Lansac J (2003) Apport du Doppler pour le diagnostic des tumeurs ovariennes. J Radiol 84:1725–1731

    PubMed  CAS  Google Scholar 

  2. Zanetta G, Vergani P, Lissoni A (1994) Color Doppler ultrasound in the preoperative assessment of adnexal masses. Acta Obstet Gynecol Scand 73:637–641

    PubMed  CAS  Google Scholar 

  3. Timor-Tritsch LE, Lerner JP, Monteagudo A, Santos R (1993) Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol 168:909–913

    PubMed  CAS  Google Scholar 

  4. Valentin L, Sladkevicius P, Marsal K (1994) Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 83:425–433

    PubMed  CAS  Google Scholar 

  5. Alcazar JL, Ruiz-Perez ML, Errasti T (1996) Transvaginal color Doppler sonography in adnexal masses: which parameter performs best? Ultrasound Obstet Gynecol 8:114–119

    Article  PubMed  CAS  Google Scholar 

  6. Valentin L (1999) Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 14:273–283

    Article  PubMed  CAS  Google Scholar 

  7. Timmerman D, Valentin L, Bourne TH et al (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505

    Article  PubMed  CAS  Google Scholar 

  8. Tailor A, Jurkovic D, Bourne TH et al (1998) Comparison of transvaginal color Doppler imaging and color Doppler energy for assessment of intraovarian blood flow. Obstet Gynecol 91:561–567

    Article  PubMed  CAS  Google Scholar 

  9. Merce LT, Caballero RA, Barco MJ et al (1998) B-mode, utero-ovarian and intratumoral transvaginal colour Doppler ultrasonography for differential diagnosis of ovarian tumours. Eur J Obstet Gynecol Reprod Biol 76:97–107

    Article  PubMed  CAS  Google Scholar 

  10. Kinkel K, Hricak H, Lu Y et al (2000) US characterization of ovarian masses: a meta-analysis. Radiology 217:803–811

    PubMed  CAS  Google Scholar 

  11. Marret H, Ecochard R, Giraudeau B et al (2002) Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models. Ultrasound Obstet Gynecol 20:597–604

    Article  PubMed  CAS  Google Scholar 

  12. Junor EJ, Hole DJ, McNulty L et al (1999) Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 106:1130–1136

    PubMed  CAS  Google Scholar 

  13. Eisenkop SM, Spirtos NM, Montag TW et al (1992) The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 47:203–209

    Article  PubMed  CAS  Google Scholar 

  14. Kehoe S, Powell J, Wilson S, Woodman C (1994) The influence of the operating surgeon’s specialisation on patient survival in ovarian carcinoma. Br J Cancer 70:1014–1017

    PubMed  CAS  Google Scholar 

  15. Carney ME, Lancaster JM, Ford C et al (2002) A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 84:36–42

    Article  PubMed  Google Scholar 

  16. Epstein E, Skoog L, Isberg PE et al (2002) An algorithm including results of grey-scale and power Doppler ultrasound examination to predict endometrial malignancy in women with postmenopausal bleeding. Ultrasound Obstet Gynecol 20:370–376

    Article  PubMed  CAS  Google Scholar 

  17. Fleischer AC, Wojcicki WE, Donnelly EF et al (1999) Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med 18:547–551

    PubMed  CAS  Google Scholar 

  18. Amso NN, Watermayer SR, Pugh N et al (2001) Quantification of power Doppler energy and its future potential. Fertil Steril 76:583–587

    Article  PubMed  CAS  Google Scholar 

  19. Marret H, Sauget S, Giraudeau B et al (2005) Power Doppler vascularity index for predicting malignancy of adnexal masses. Ultrasound Obstet Gynecol 25:508–513

    Article  PubMed  CAS  Google Scholar 

  20. Correas JM, Bridal L, Lesavre A et al (2001) Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11:1316–1328

    Article  PubMed  CAS  Google Scholar 

  21. Suren A, Osmers R, Kulenkampff D, Kuhn W (1994) Visualization of blood flow in small ovarian tumor vessels by transvaginal colour Doppler sonography after echo enhancement with injection of Levovist. Gynecol Obstet Invest 38:210–212

    Article  PubMed  CAS  Google Scholar 

  22. Orden MR, Gudmundsson S, Kirkinen P (2000) Contrast-enhanced sonography in the examination of benign and malignant adnexal masses. J Ultrasound Med 19:783–788

    PubMed  CAS  Google Scholar 

  23. Szymanski M, Szymanski W, Grabiec M, Korenkiewicz J (1999) Evaluation of using Levovist in the differential diagnosis of ovarian tumors. Ginekol Pol 70:444–449

    PubMed  CAS  Google Scholar 

  24. Kupesic S, Kurjak A (2000) Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses. Obstet Gynecol 96:452–458

    Article  PubMed  CAS  Google Scholar 

  25. Orden MR, Jurvelin JS, Kirkinen PP (2003) Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 226:405–410

    PubMed  Google Scholar 

  26. Marret H, Sauget S, Giraudeau B et al (2004) Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med 23:1629–1639

    PubMed  Google Scholar 

  27. Morel DR., Schwieger I, Hohn L (2000) Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35:80–85

    Article  PubMed  CAS  Google Scholar 

  28. Testa A, Ferrandina G, Fruscella E et al (2005) The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases. J Ultrasound Med 24:1261–1266

    Google Scholar 

  29. Marret H, Brewer M, Giraudeau B et al (2005) Ovine model to evaluate ovarian vascularization using contrast-enhanced sonography. Comparative Medicine 55:150–155

    PubMed  CAS  Google Scholar 

  30. Seidel G, Vidal-Langwasser M, Algermissen C et al (1999) The influence of Doppler system settings on the clearance kinetics of different ultrasound contrast agents. Eur J Ultrasound 9:167–175

    Article  PubMed  CAS  Google Scholar 

  31. Halpern EJ, Rosenberg M, Gomella LG (2001) Prostate cancer: contrast-enhanced US for detection. Radiology 219:219–25

    PubMed  CAS  Google Scholar 

  32. Emoto M, Fujimitsu R, Hiwasaki H, Kawarabayashi T (2003) Normal sized ovarian cancer detected by colour Doppler Ultrasound using a microbubble contrast agent. J Clin Oncol 21:3703–3705

    Article  PubMed  Google Scholar 

  33. Cheng WF, Lee CN, Chen CA et al (1999) Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 85:651–657

    Article  PubMed  CAS  Google Scholar 

  34. Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16:407–422

    Article  PubMed  Google Scholar 

  35. Watson GM, Walker WJ (2002) Uterine artery embolisation for treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women’s views of success treatment. BJOG 109:129–135

    PubMed  CAS  Google Scholar 

  36. Brunereau L, Herbreteau D, Gallas S et al (2000) Uterine artery embolization in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients. AJR Am J Roentgenol 175:1267–1272

    PubMed  CAS  Google Scholar 

  37. Spies JB, Scialli AR, Jha RC et al (1999) Initial results from uterine fibroid embolization for symptomatic leiomyomata. J Vasc Interv Radiol 10:1149–1157

    Article  PubMed  CAS  Google Scholar 

  38. Pelage JP, Le Dref O, Soyer P et al (2000) Fibroid related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology 215:428–431

    PubMed  CAS  Google Scholar 

  39. Tranquart F, Brunereau L, Cottier JP et al (2002) Prospective sonographic assessment of uterine artery embolization for the treatment of fibroids. Ultrasound Obstet Gynecol 19:81–87

    Article  PubMed  CAS  Google Scholar 

  40. Amato P, Roberts AC (2001) Transient ovarian failure: a complication of uterine artery embolization. Fertil Steril 75:438–439

    Article  PubMed  CAS  Google Scholar 

  41. Stringer NH, Grant T, Park J, Oldham L (2000) Ovarian failure after uterine artery embolization for treatment of myomas. J Am Assoc Gynecol Laparosc 7:395–400

    Article  PubMed  CAS  Google Scholar 

  42. Spies JB (2003) Uterine artery embolization for fibroids: understanding the technical causes of failures. J Vasc Interv Radiol 14:11–14

    PubMed  Google Scholar 

  43. Marret H, Tranquart F, Sauget S et al (2004) Contrast-enhanced sonography during Myomas embolization Ultrasound Obstet Gynecol 23:77–79

    CAS  Google Scholar 

  44. Muniz CJ, Fleischer AC, Donnelly EF, Mazer MJ (2002) Three-dimensional color Doppler sonography and uterine artery arteriography of fibroids: assessment of changes in vascularity before and after embolization. J Ultrasound Med 21:129–133

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology, Obstetrics, Fetal Medicine and Human Reproduction Bretonneau Hospital, CHRU Tours, Tours, France

    Henri Marret & Stéphane Sauget

  2. Department of Gynecology Oncology, University of Arizona, Arizona Cancer Center, Tucson, USA

    Molly Brewer

  3. Department of Medical Imaging, Nuclear Medicine and Ultrasound Bretonneau Hospital, CHRU Tours, Tours, France

    François Tranquart

Authors
  1. Henri Marret
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stéphane Sauget
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Molly Brewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. François Tranquart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy

    Riccardo Lencioni

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Marret, H., Sauget, S., Brewer, M., Tranquart, F. (2006). Recent Advances in Contrast-Enhanced Ultrasound in Woman Pelvis Lesions. In: Lencioni, R. (eds) Enhancing the Role of Ultrasound with Contrast Agents. Springer, Milano. https://doi.org/10.1007/88-470-0476-4_17

Download citation

  • DOI: https://doi.org/10.1007/88-470-0476-4_17

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0475-7

  • Online ISBN: 978-88-470-0476-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation